INTRODUCTION
The molecular mechanisms that lead to defective (3-globin chain synthesis in the 3 thalassemia syndromes are extremely heterogeneous (1) (2) (3) . Deletions of various segments of DNA on chromosome 11 in the hereditary persistence of fetal hemoglobin (7) (8) (9) (10) (11) (12) , and y8(8 thalassemia (13, 14) . The more common types of(8 thalassemia, however, are not the result of gene deletions. The nondeletion thalassemias, which are usually accompanied by elevated hemoglobin A2 levels, are divided into two broad categories: +3+ thalassemia, in which (8-globin chain synthesis is reduced but detectable, and (83 thalassemia, in which no (l-globin chains are produced (15, 16) . The molecular defects in these forms of ( thalassemia are currently under investigation with molecular cloning, DNA sequence analysis, and functional assays. Recent studies suggest that some (8+ thalassemia may be due to defective processing of the primary (3-globin messenger RNA (mRNA) transcript into mature mRNA (17, 18) .
The molecular bases of (0 thalassemia are also heterogeneous. In some individuals, (-globin mRNA synthesis is absent; in others, a variable quantity is demonstrable in the reticulocyte (19) . Previously we investigated the lesion in the mRNA from a Chinese patient affected by (30 thalassemia where (3-globin mRNA was detectable (20, 21) , and found the defect to be a nonsense mutation that caused premature termination of the ,8-globin chain (22) . In this study we investigated thalassemia on the island of Sardinia (23) , where (0 thalassemia, the predominant molecular form, is characterized by low levels of (8-globin mRNA. We cloned the complementary DNA (cDNA), isolated and sequenced a (3-globin cDNA clone, and found that the lesion was also due to a nonsense mutation, although in a different position from that in the Chinese. This study further illustrates the heterogeneity of the lesions that produce 8 thalassemia.
METHODS RNA and DNA preparation and analysis. Previous studies (23) . We prepared poly (A+) RNA from 20 patients and cellular DNA from 10 patients, as previously described (21, 24) . RNA from 20 patients and DNA from five patients was quantitated by solution hybridization with cDNA enriched in a-and 18-globin sequences as previously described (20, 24) . Genomic DNA from 10 patients was digested with the enzymes Hpa I, Bam HI, Pst I, and Eco RI (Bethesda Research Laboratories, Gaithersburg, Md.) and analyzed by Southern blotting. The globin-gene containing fragments were identified by 32P_ labeled cDNA or by nick-translated f8-globin cDNA as described (25) .
Cell-free synthesis. Poly(A+) RNA from five patients was pooled and the ,B-globin mRNA was enriched by selective adsorption to f3-globin cDNA covalently bound to cellulose. The f3-globin cDNA recombinant plasmid (pJW 102) (26) was covalently bound to diazotyzed cellulose by the method of Noyes and Stark (27) , the only modification being the use of 200 mM borate buffer at pH 6.0. A small amount of radioactive 83-globin cDNA was used to monitor the coupling efficiency, which was found to be 1.8 ,g of pJW 102/mg of cellulose. Poly(A+) RNA (200 ng) was hybridized to 5 mg (3-globin cDNA cellulose in a 65-,ul hybridization buffer containing 60% formamide (vol/vol), 150 mM NaCl, 25 mM Tris-HC1 (pH 7.5), 1.0 mM EDTA, 0.1 g/100 ml SDS, and 0.25 mg/ml wheat germ transfer RNA (tRNA), with constant inversion at 37°C for 44 h. The cellulose was then washed twice with the 100-,ul hybridization mixture and twice with the mixture without tRNA at 37°C. The bound mRNA was eluted at 65°C in two 50-.ld aliquots of hybridization buffer. The RNA was precipitated in 70% (vol/vol) ethanol at -20°C after adding 20 yg/ml deacylated wheat germ tRNA and 200 mM potassium acetate (pH 7.5).
The ability ofthe enriched /3-globin mRNA to direct protein synthesis was assayed in a micrococcal nuclease-treated rabbit reticulocyte lysate system (28) temperature. An average of 33 dCMP residues was added to the 3' end of the cDNA. The reaction was extracted with phenol and precipitated in ethanol.
To synthesize the complementary strand, the oligo dCtailed single-stranded cDNA was incubated for 2.5 h at room temperature with 2 nmol dG12_18,, 500 uM each of dATP, dGTP, and TTP, 100 ,uM a-[32P]dCTP (sp act 10 Ci/mmol), and 54 U AMV reverse transcriptase in 40 ,u of the same buffer used to synthesize the first strand. The mixture was extracted with phenol, fractionated on a Sephadex G-75 column, and the resulting double-stranded cDNA was precipitated in ethanol. A dC tail was added to the 3' end of the doublestranded cDNA by incubation with terminal deoxynucleotidyl transferase and dCTP for 15 min under the tailing conditions given above. An average of 130 dCMP residues was added to each end.
Preparation of the plasmid vector. 5 ,ug of the plasmid pBR 322 was linearized by digestion with Pst I and dG tails were added by incubating the cleaved plasmid for 3 h at room temperature in the described tailing buffer containing 100
,uM a-[32P]dGTP (New England Nuclear, Boston, Mass.) diluted to sp act 24 Ci/mmol), 0.1 ,ug/,ul gelatin, and 35 U terminal deoxynucleotidyl transferase, with a second addition of 15 U TDT at 37°C for 15 h. An average of six guanosine 5'-monophosphate residues was added to each 3' end.
Equimolar amounts (0.074 pmol each) of the doublestranded cDNA (dC-tailed) and the pBR 322 (dG-tailed) were annealed to each other by incubating 200 ,ug cDNA with 28 ,ug pBR 322 in a 200-,ul mixture containing 100 mM NaCl, 1 mM Tris-HCl (pH 7.5), and 0.1 mM EDTA. The reaction mixture was heated to 70°C and allowed to cool slowly to 42°C over -30 h, and then to room temperature overnight and stored at 4°C.
Transformation and isolation of the f3cDNA clone. Escherichia coli of the strain X 1776 was prepared for transformation according to previously described methods (32, 33) . 200 ,ul of the above-mentioned annealing mixture was incubated with 400 1.l of calcium-treated X 1776 at 4°C for 1 h. 600 ,ul L broth was added, and the entire mixture was heated for 3 min at 42°C and incubated at 37°C for 30 min. The mixture was grown at 37°C on L broth agar plates supplemented with diaminopimelic acid (100 ,g/ml), thymidine (840 ,ug/ml), and tetracycline (15 ,g/ml). Colonies appeared over the next 2 d.
Colonies were screened by in situ filter hybridization with a nick-translated ,8-globin cDNA probe excised from the /3 cDNA-containing recombinant plasmid pNC 1-71. Filters were hybridized and washed under conditions similar to those previously reported (34) , with the final wash at 55°C
for 2 h to decrease cross hybridization of the /8-globin probe with y-and 8-globin sequences.
Colonies that hybridized strongly with the 83-cDNA probe I Liebhaber, S. A. Unpublished observation.
were grown in 25 ml culture and plasmid was prepared from a clarified lysate by banding on a CsCl gradient. 1 jAg of each plasmid was digested with Pst I and the recombinant (pSAR 6) with the largest insert (-600 base pairs) was used to transform the host HblOl, grown in M-1 medium to OD630 0.77, and amplified with 150 ,ug/ml chloramphenicol.
The plasmid supercoil was isolated from a clarified lysate. DNA sequencing. The complete sequence of the (-globin cDNA insert was determined by the Maxam and Gilbert method (35) , with a modification in the A reaction (31) Solution hybridization of the labeled cDNA to cellular DNA showed that the DNA from these Sardinian patients contained the full complement of f8-globin genes. The structure of these 3-globin genes was normal by Southern blot analysis; the sizes of 8-globin gene-containing fragments generated by cleavage with Eco RI, Bam HI, Pst I, and Hpa I were identical to normal controls. (The DNA data are not shown.)
Analysis of thefunction ofthe /3-globin mRNA. We previously showed that the nonsense mutation respon- When the yeast serine inserting amber suppressor tRNA was added, a small but definite radioactivity peak in the /8-globin chain region was clearly discernible (Fig. 2) . We pooled the [35S]methioninelabeled globin in this fraction, digested it with trypsin, and separated the peptides by high voltage electrophoresis. We identified the methionine-containing peptide with,S-T5 as previously described (29) (result of peptide analysis is not shown).
In our previously reported Chinese ( thalassemia patient, the normal codon for the 17th amino acid AAG (lysine) is changed to the amber termination codon UAG (22) . Placing a serine in this position with a serine inserting amber suppressor tRNA produces a more acidic globin chain, which elutes earlier than the (3A chain on chromatography (29) . In the Sardinian patient, inserting serine in a UAG codon produced a ,8-globin chain with the same electrophoretic charge as the normal /3A. This indicates that the / Sardinia mutation affects a codon for a neutral amino acid and is therefore different from the 3 Chinese mutation.
A single nucleotide mutation affecting codons for the neutral amino acids leucine, serine, glutamine, tyrosine, or tryptophan can produce a UAG codon. inset, the radioactivity scale was expanded 10-fold to show that JRE 1 Rate of annealing of a-and f3-globin cDNA to an authentic /8-globin peak appeared over the background ulocyte RNA from a Sardinian 3 thalassemia patient. radioactivity in response to the addition of the suppressor 32P-labeled a-globin cDNA; 0, 3H-labeled ,8-globin tRNA. The a-globin peaks, which were unaffected by addition [A. of suppressor tRNA, are not shown.
However, the leucine codon (UUG) and the serine codon (UCG) are not used in the human /8-globin mRNA (36 Fig. 3 . Two changes from the published f8-globin mRNA sequences (36) were observed and confirmed by sequencing both cDNA strands. First, at the position corresponding to amino acid 53, the alanine was encoded by GCU. This sequence differs from the codon (GCA) reported by Marotta et al. (36) the result published by Lawn et al. (37) , and represents a silent third-base substitution. The second change occurred at amino acid 39 where the codon CAG (glutamine) was changed to UAG, an amber termination codon (Fig. 4) (38) . Our study shows that this mutation is produced by a single nucleotide change at codon number 39, where CAG is changed to the termination codon UAG. In accordance with previously proposed terminology, this mutant is designated either 839CAG-4UAG or 139UAG. This is the second example of a nonsense mutation found in humans. A review of the nucleotide sequence of,-globin mRNA showed a single nucleotide mutation in the coding region could result in termination codons in 29 positions. Hence, one would expect to find a subgroup of , thalassemia that is due to different nonsense mutations.
In both Sardinians and Chinese with nonsense mutations, there is a decreased amount of 18-globin mRNA in the reticulocyte. It has been postulated that the lack of ribosomal binding to a large section of the mRNA may expose it to nuclease degradation (22, 29) . But we do not know why the 8/a globin mRNA ratio is lower in the Sardinian with a termination codon at amino acid position number 39 than in the Chinese with the termination codon at position 19 . Other factors, such as the effect of the mutation on secondary mRNA structure, could influence the mRNA level in the reticulocyte. Studies of termination codon mutations at other positions on the 13-globin chain may explain the mechanism of mRNA degradation.
Low level mRNA hybridization of the 18-globin cDNA probe in 1 thalassemia has often been ascribed to a cross-reaction with 8-globin mRNA (19) . This study further emphasizes that a low mRNA level does not rule out the presence of a 1-globin mRNA.
,30 thalassemia comprises a heterogeneous group of disorders. In addition to nonsense mutations, other possibilities include defective mRNA transcription resulting in the absence of 13-globin mRNA synthesis, and abnormal processing causing incomplete degradation of 8-globin mRNA in the nucleus. Our study illustrates the efficacy of the suppressor tRNA assay as a means of distinguishing the nonsense mutation from other causes.
